Recombinant Human DCTN1 Protein，His & SUMO

DCTN1, or Dynactin Subunit 1, is a crucial component of the dynactin complex, which plays an essential role in cellular processes such as intracellular transport, mitosis, and the maintenance of cell shape. Mutations in the DCTN1 gene are associated with neurodegenerative diseases, particularly familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), highlighting its importance in neuronal function and health. Given its role in cellular dynamics, DCTN1 offers a promising target for therapeutic interventions. Research into DCTN1 recombinant proteins has gained traction as scientists aim to elucidate its structure-function relationships and regulatory mechanisms. By producing and characterizing recombinant DCTN1 proteins, researchers can gain insights into the molecular underpinnings of its interactions with motor proteins like dynein and kinesin, which are pivotal for vesicle transport along microtubules. Furthermore, understanding the biochemical properties of DCTN1 can aid in identifying pathways that lead to its dysfunction in neurodegenerative diseases. This line of investigation is not only vital for developing potential treatments but also provides a broader understanding of the fundamental aspects of cell biology and neurobiology. As such, DCTN1 recombinant protein studies are an integral part of ongoing research aimed at tackling the challenges posed by motor neuron diseases and advancing the field of neurodegeneration research.